Neufahrn, Germany

Uwe Konopka



Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Uwe Konopka: Innovator in Plasma Technology

Introduction

Uwe Konopka is a notable inventor based in Neufahrn, Germany. He has made significant contributions to the field of plasma technology, holding a total of 4 patents. His work focuses on methods and devices that enhance the operation and manipulation of plasma systems.

Latest Patents

One of his latest patents is titled "Method and device for the operation of a plasma device." This invention describes a method in which particles are arranged in a plasma, utilizing electric traveling waves to direct the movement of these particles to predetermined collection areas. Additionally, he has developed a "Device for specific particle manipulation and deposition." This process allows for the manipulation of particles in a plasma environment, ensuring that they do not form a plasmacrystalline state. The invention enables location-selective exposure to external forces, allowing for precise application of particles onto substrate surfaces.

Career Highlights

Throughout his career, Uwe Konopka has worked with esteemed organizations, including the Max Planck Society for the Advancement of Science. His innovative approaches have positioned him as a key figure in the advancement of plasma technology.

Collaborations

Uwe has collaborated with notable colleagues such as Gregor Eugen Morfill and Timo Stuffler. Their combined expertise has contributed to the development of groundbreaking technologies in the field.

Conclusion

Uwe Konopka's contributions to plasma technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and advance the understanding of plasma systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…